This is consistent with the finding that ACPA targeting a citrullinated histone H4 peptide (CitH431-50) were detectable in a subset of pre-symptomatic Swedish individuals who subsequently developed RA [39]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.